Literature DB >> 6779018

Implications for health care policy. A social and demographic profile of hemodialysis patients in the United States.

R W Evans, C R Blagg, F A Bryan.   

Abstract

Before 1973, selection of patients with end-stage renal diseases (ESRD) for treatment was necessary because of inadequate medical and financial resources. Patients were selected based partly on social worth rather than medical suitability. In 1973 ESRD patients became eligible for Medicare benefits, eliminating the financial barrier to treatment. Using data from two national surveys of hemodialysis patients in 1967 and 1978, two social and demographic profiles of patients illustrate the effect of extension of Medicare benefits on composition of the dialysis patient population. These data indicate that problems of patient selection have been resolved, and ESRD patients now have equal access to medical care. Nevertheless, there is growing pressure for cost efficiency for the ESRD program in the tightening economic climate. This may lead again to some form of restriction for future access to dialysis therapy.

Entities:  

Keywords:  Empirical Approach; End Stage Renal Disease Program

Mesh:

Year:  1981        PMID: 6779018     DOI: 10.1001/jama.245.5.487

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

Review 1.  Differences in clinical communication by gender.

Authors:  V Elderkin-Thompson; H Waitzkin
Journal:  J Gen Intern Med       Date:  1999-02       Impact factor: 5.128

2.  Patients, populations and policy: patient outcomes in chronic kidney disease.

Authors:  N R Powe
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

Review 3.  Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.

Authors:  Kimberly Harding; Tesfaye B Mersha; Fern A Webb; Joseph A Vassalotti; Susanne B Nicholas
Journal:  Am J Nephrol       Date:  2017-08-05       Impact factor: 3.754

4.  End-stage renal disease in blacks: a national or international problem?

Authors:  M G Dillard; C O Callender
Journal:  J Natl Med Assoc       Date:  1984-12       Impact factor: 1.798

Review 5.  Chronic Hemodialysis Therapy in the West.

Authors:  Michael V Rocco
Journal:  Kidney Dis (Basel)       Date:  2015-11-18

6.  The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

Authors:  T Sugimoto; S J Rosansky
Journal:  Am J Public Health       Date:  1984-01       Impact factor: 9.308

7.  Twenty years of Medicare and Medicaid: covered populations, use of benefits, and program expenditures.

Authors:  M Gornick; J N Greenberg; P W Eggers; A Dobson
Journal:  Health Care Financ Rev       Date:  1985

8.  The costs in provision of haemodialysis in a developing country: a multi-centered study.

Authors:  Priyanga Ranasinghe; Yashasvi S Perera; Mohamed F M Makarim; Aruna Wijesinghe; Kamani Wanigasuriya
Journal:  BMC Nephrol       Date:  2011-09-06       Impact factor: 2.388

9.  Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis.

Authors:  Robert N Foley; Qiao Fan; Jiannong Liu; David T Gilbertson; Eric D Weinhandl; Shu-Cheng Chen; Allan J Collins
Journal:  BMC Nephrol       Date:  2008-06-26       Impact factor: 2.388

10.  Cross-national differences in dialysis rates.

Authors:  J Prottas; M Segal; H M Sapolsky
Journal:  Health Care Financ Rev       Date:  1983-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.